• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨免疫学:风湿病学家备忘录。

Osteoimmunology: memorandum for rheumatologists.

机构信息

Department of Rheumatology & Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing, 100730, China.

Department of Rheumatology, the First People's Hospital of Yueyang, Yueyang, 414000, China.

出版信息

Sci China Life Sci. 2016 Dec;59(12):1241-1258. doi: 10.1007/s11427-016-5105-7. Epub 2016 Sep 20.

DOI:10.1007/s11427-016-5105-7
PMID:27650950
Abstract

Rapid progress has been made in exploring the connections between the skeletal system and the immune system over the past decade. Bone tissue forms developmental niches for hematopoietic stem cells, and activated immune cells are involved in bone metabolism regulation and are potent mediators of osteoporosis and bone erosion under pathological conditions. The interdisciplinary field of osteoimmunology has emerged to pool the knowledge of the interdependence of these two systems, including the shared ligands and receptors, their crosstalk and interaction, and common intracellular signaling pathways with bidirectional influence. The receptor activator of nuclear factor-kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) triad is the key vinculum, with multifaceted potency, being not only essential for osteoclastogenesis but also critical for lymph node organogenesis and lymphopoiesis as well as for immune regulation. In this review, we summarize the progress in this area, focusing on those aspects of interest concerning rheumatic diseases.

摘要

在过去的十年中,人们在探索骨骼系统和免疫系统之间的联系方面取得了快速进展。骨组织为造血干细胞形成发育龛,激活的免疫细胞参与骨代谢调节,并在病理条件下成为骨质疏松症和骨质侵蚀的有力介质。骨免疫学这一交叉学科领域汇集了这两个系统相互依存的知识,包括共享的配体和受体、它们的串扰和相互作用以及具有双向影响的共同细胞内信号通路。核因子-κB 受体激活剂(RANK)/RANK 配体(RANKL)/骨保护素(OPG)三联体是关键的连接物,具有多方面的功能,不仅对破骨细胞形成至关重要,而且对淋巴结发生和淋巴生成以及免疫调节也至关重要。在这篇综述中,我们总结了这一领域的进展,重点关注与风湿性疾病有关的方面。

相似文献

1
Osteoimmunology: memorandum for rheumatologists.骨免疫学:风湿病学家备忘录。
Sci China Life Sci. 2016 Dec;59(12):1241-1258. doi: 10.1007/s11427-016-5105-7. Epub 2016 Sep 20.
2
RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases.核因子κB受体活化因子配体、核因子κB受体活化因子、骨保护素:骨免疫学和血管疾病的关键伙伴。
Cell Mol Life Sci. 2007 Sep;64(18):2334-50. doi: 10.1007/s00018-007-7104-0.
3
Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).骨及其他组织中的核因子κB受体激活剂配体(RANKL)/核因子κB受体激活剂(RANK)/骨保护素系统(综述)
Mol Med Rep. 2015 May;11(5):3212-8. doi: 10.3892/mmr.2015.3152. Epub 2015 Jan 7.
4
New insights into osteoclastogenic signaling mechanisms.破骨细胞生成信号机制的新见解。
Trends Endocrinol Metab. 2012 Nov;23(11):582-90. doi: 10.1016/j.tem.2012.05.005. Epub 2012 Jun 15.
5
Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.骨龛与免疫系统的串扰:作为癌症治疗潜在靶点的骨免疫学信号
Cancer Treat Rev. 2015 Feb;41(2):61-8. doi: 10.1016/j.ctrv.2014.12.001. Epub 2014 Dec 8.
6
Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.骨免疫学:统一免疫系统和骨骼系统的概念框架。
Physiol Rev. 2017 Oct 1;97(4):1295-1349. doi: 10.1152/physrev.00036.2016.
7
TNF conference 2009: beyond bones - RANKL/RANK in the immune system.2009年肿瘤坏死因子会议:超越骨骼——免疫系统中的核因子κB受体活化因子配体/核因子κB受体活化因子
Adv Exp Med Biol. 2011;691:5-22. doi: 10.1007/978-1-4419-6612-4_2.
8
Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints.RANK、RANKL和OPG在健康及患有关节炎的犬肘关节中的免疫组织化学定位
Vet Surg. 2009 Aug;38(6):780-6. doi: 10.1111/j.1532-950X.2009.00566.x.
9
Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors.用于鉴定基序特异性RANK信号通路抑制剂的基于细胞的检测策略。
Assay Drug Dev Technol. 2006 Aug;4(4):473-82. doi: 10.1089/adt.2006.4.473.
10
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.骨保护素/RANK/RANKL 系统:血管疾病的关键之骨。
J Endocrinol Invest. 2009;32(4 Suppl):6-9.

引用本文的文献

1
Global trends in osteoimmunology and osteoporosis research: A bibliometric analysis from 2013 to 2022.骨免疫学与骨质疏松症研究的全球趋势:2013年至2022年的文献计量分析
Medicine (Baltimore). 2025 May 2;104(18):e42367. doi: 10.1097/MD.0000000000042367.
2
Association between fibrinogen and bone mineral density in postmenopausal women.绝经后妇女中纤维蛋白原与骨密度的关系。
J Orthop Surg Res. 2023 May 22;18(1):376. doi: 10.1186/s13018-023-03785-7.
3
Neuroendocrine-Immune Regulatory Network of Oliver.奥立弗的神经内分泌-免疫调节网络。
Molecules. 2022 Jun 8;27(12):3697. doi: 10.3390/molecules27123697.
4
Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation the NF-κB and MAPK Pathways.石榴皮素通过抑制破骨细胞生成以及炎症反应的NF-κB和MAPK信号通路对骨质疏松症的保护作用
Front Pharmacol. 2020 May 15;11:696. doi: 10.3389/fphar.2020.00696. eCollection 2020.
5
Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.利用中药防治骨质疏松症:特别强调免疫调节机制。
J Immunol Res. 2018 Feb 20;2018:6345857. doi: 10.1155/2018/6345857. eCollection 2018.